Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 801 to 850 of 2003

TitleReference numberPublishedLast updated
Peripheral arterial disease: diagnosis and managementCG147
Low back pain and sciatica in over 16s: assessment and managementNG59
Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemiaTA663
Liraglutide for managing overweight and obesityTA664
Upadacitinib for treating severe rheumatoid arthritisTA665
Zio XT for detecting cardiac arrhythmiasMTG52
Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancerTA660
Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinomaTA661
Durvalumab in combination for untreated extensive-stage small-cell lung cancer (terminated appraisal)TA662
Swallowable gastric balloon capsule for weight lossIPG684
Acute coronary syndromesNG185
Drug-eluting stents for the treatment of coronary artery diseaseTA152
Siponimod for treating secondary progressive multiple sclerosisTA656
Carfilzomib for previously treated multiple myelomaTA657
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myelomaTA658
Galcanezumab for preventing migraineTA659
Guidance on the use of coronary artery stentsTA71
Human and animal bites: antimicrobial prescribingNG184
Testing strategies for Lynch syndrome in people with endometrial cancerDG42
Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosisIPG681
Balloon cryoablation for Barrett's oesophagusIPG682
Balloon cryoablation for squamous dysplasia of the oesophagusIPG683
Volanesorsen for treating familial chylomicronaemia syndromeHST13
Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapyTA655
SEM Scanner 200 for preventing pressure ulcersMTG51
Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancerTA653
Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancerTA654
Rheumatoid arthritis in adults: managementNG100
Behaviour change: digital and mobile health interventionsNG183
Naldemedine for treating opioid-induced constipationTA651
Pembrolizumab with axitinib for untreated advanced renal cell carcinomaTA650
Transcranial magnetic stimulation for auditory hallucinationsIPG680
Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphomaTA649
Neuropathic pain in adults: pharmacological management in non-specialist settingsCG173
Insect bites and stings: antimicrobial prescribingNG182
Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)TA648
Axonics sacral neuromodulation system for treating refractory overactive bladderMTG50
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic strokeDG41
Avelumab with axitinib for untreated advanced renal cell carcinomaTA645
Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal)TA646
Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal)TA647
High-sensitivity troponin tests for the early rule out of NSTEMIDG40
Anaphylaxis: assessment and referral after emergency treatmentCG134
Surgical site infections: prevention and treatmentNG125
Perioperative care in adultsNG180
Rehabilitation for adults with complex psychosisNG181
Implanted vagus nerve stimulation for treatment-resistant depressionIPG679
Deep brain stimulation for refractory epilepsy in adultsIPG678
Entrectinib for treating NTRK fusion-positive solid tumoursTA644
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphomaTA641

Results per page

  1. 10
  2. 25
  3. 50
  4. All